![Saqib Islam](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Saqib Islam
Directeur/Membre du Conseil chez
ARS PHARMACEUTICALS, INC.
Fortune : 139 660 $ au 31/05/2026
Profil
Saqib Islam is currently Chief Executive Officer & Director at Beeline Medicines Corp.
since 2025.
Since 2018, the role of Chief Executive Officer & Director is held at SpringWorks Therapeutics LLC, starting in 2017.
Independent Director at ARS Pharmaceuticals, Inc. since 2017.
Chief Business Officer at ModernaTX, Inc. since 2016.
Former roles include Chief Executive Officer & Director at Springworks Therapeutics, Inc. from 2018 to 2025.
Managing Director at Morgan Stanley from 2000 to 2009.
Managing Director at Credit Suisse Asset Management LLC from 2009 to 2012.
Independent Director at ARYA Sciences Acquisition Corp.
III from 2020 to 2021.
Independent Non-Executive Director at Passage Bio, Inc. from 2019 to 2025.
Independent Director at Silverback Therapeutics, Inc. from 2017 to 2022.
Executive VP, Chief Strategy & Portfolio Officer at Alexion Pharmaceuticals, Inc. from 2013 to 2016.
Principal at The Boston Consulting Group, Inc. Principal at Merrill Lynch & Co., Inc. Chief Business Officer at Moderna, Inc. from 2016 to 2017.
Education includes undergraduate studies at McGill University and graduate studies at Columbia Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/06/2026 | 15 239 ( 0,02 % ) | 138 218 $ | 31/05/2026 | |
PASSAGE BIO, INC. 0,01 % | 28/05/2025 | 250 ( 0,01 % ) | 1 443 $ | 31/05/2026 |
Postes actifs de Saqib Islam
| Sociétés | Poste | Début |
|---|---|---|
| ARS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/07/2017 |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Corporate Officer/Principal | 09/05/2016 |
SpringWorks Therapeutics LLC
 SpringWorks Therapeutics LLC BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company that develops oncology medicines | Directeur Général | 01/08/2018 |
Anciens postes connus de Saqib Islam
| Sociétés | Poste | Fin |
|---|---|---|
| PASSAGE BIO, INC. | Directeur/Membre du Conseil | 16/09/2025 |
| SPRINGWORKS THERAPEUTICS, INC. | Directeur Général | 01/07/2025 |
| ARS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/01/2022 |
| ARYA SCIENCES ACQUISITION III A | Directeur/Membre du Conseil | 01/11/2021 |
| MODERNA, INC. | Corporate Officer/Principal | 01/08/2017 |
Formation de Saqib Islam
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Morgan Stanley
 Morgan Stanley Investment ManagersFinance Provides wealth and asset management, trading & investment banking services | Finance |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Credit Suisse Asset Management LLC
 Credit Suisse Asset Management LLC Investment ManagersFinance CSAM aims to drive long-term performance and positive impact beyond returns. | Finance |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia Law School
 Columbia Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Health Technology |
Merrill Lynch & Co., Inc.
 Merrill Lynch & Co., Inc. Investment ManagersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Finance |
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company that develops oncology medicines | Health Technology |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Springworks Therapeutics, Inc.
 Springworks Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes medicines for nervous system disorders | Health Technology |
ARYA Sciences Acquisition Corp. III
 ARYA Sciences Acquisition Corp. III Financial ConglomeratesFinance Operates as a blank check company | Finance |
ARS Pharmaceuticals, Inc.
 ARS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
